Polase

Quick links to important sections

Polase

Method of action: Mineral Supplements, Tonics

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Polase

Property Description
Active ingredient Magnesium Aspartate, Potassium Aspartate
Form Oral Granules (Sachets), Oral Tablets
Pharmacological class Electrolyte Replacement Agent, Mineral Supplement
Common use Supporting mineral balance, reducing tiredness/fatigue
Origin Synthetic Mineral Salt Combination

Classification and Definition of Polase

Polase is classified primarily as a Dietary Supplement or Food Supplement, meaning its function is to complement the diet with essential mineral intake, which distinguishes it from prescription pharmaceutical drugs. It belongs to the high-level pharmacological class of Electrolyte Replacement Agents and Mineral Supplements. The product is intended for Oral Route of administration and is commonly presented in forms such as effervescent Oral Granules (Sachets) and Oral Tablets. This accessibility allows individuals to proactively address perceived or measured mineral deficits, making it suitable for wide use, particularly by those experiencing heightened physiological mineral loss.

Core Composition: Magnesium and Potassium Aspartates

The active ingredients are the Synthetic Mineral Salts Magnesium Aspartate and Potassium Aspartate, which provide highly bioavailable sources of the vital electrolytes Magnesium and Potassium. Magnesium is critical for over 300 enzyme systems and is essential for the proper transport and utilization of Potassium. The preparation is distinctive due to its focus on the synergistic combination of these two minerals. The inclusion of the Aspartate form, which is derived from Aspartic Acid, is specifically utilized to enhance the oral bioavailability compared to other mineral salt forms, promoting efficient absorption.

General Purpose and Function

The general purpose of this supplement is the effective Restoration of Electrolyte Balance and Replenishment of Key Minerals to support normal systemic function. Potassium and Magnesium are recognized for their essential roles in nerve impulse transmission and muscle contraction. By maintaining this critical Electrolyte Balance, the preparation supports healthy muscle function and the proper operation of the nervous system, consequently contributing to the overall reduction of general tiredness and fatigue. A typical use scenario involves its application after intense physical activity or during periods of heat exposure, where mineral loss through sweating is significant.

Regulatory References

  1. NIH Fact Sheet on Magnesium
  2. MedlinePlus Potassium

What side effects are possible with Polase?

Safety Profile and Contraindications

Polase is a mineral salt supplement containing potassium and magnesium salts, and its safety profile is primarily focused on the risks associated with potential mineral imbalances, specifically the risk of elevated potassium levels (hyperkalemia).

Officially documented warnings and safety restrictions focus on preventing use in vulnerable individuals or those taking interacting medications.

Key Safety Considerations Description
Serious Risks The primary serious risk is hyperkalemia (excessive potassium), which can be life-threatening. This risk is dose-related and significantly amplified in specific patient populations.
Contraindications The supplement is Not to be taken by individuals with abnormal kidney function (renal insufficiency) or pre-existing high potassium levels (hyperkalemia).
Drug Interactions Use is strictly cautioned against for individuals concurrently taking ACE inhibitors (Angiotensin-Converting Enzyme Inhibitors) or potassium-sparing diuretics, as these can increase systemic potassium levels and elevate the risk of hyperkalemia.

Other Adverse Reactions and Use Notes

Adverse reactions that are not classified as serious are typically related to the gastrointestinal system, such as diarrhea, cramps, or stomach pain, which are most often associated with the magnesium component. However, the exact frequency classification (e.g., very common, rare) for these non-serious effects is generally not formally documented or classified in public regulatory summaries for this type of supplement.

For pregnancy and breastfeeding, regulatory notes recommend that use should only occur under the advice of a doctor or healthcare professional to ensure safety for both mother and child.

In the event of overdose or prolonged use, regulatory warnings advise immediate consultation with a doctor or poison control center. This overall safety structure is designed to mitigate the primary risks associated with the intake of high doses of potassium and magnesium salts.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Polase, characterized by excessive exposure to the active mineral salts, results in documented severe Hyperkalemia and Hypermagnesemia. These imbalances lead to systemic clinical manifestations and carry a documented risk of life-threatening outcomes.

Documented Manifestations and Scope System Manifestations
Cardiovascular Hypotension, severe ECG changes (QRS widening, peaked T-waves).
Neuromuscular Muscle weakness, deep tendon reflex loss (areflexia), somnolence.
Severe Outcomes Cardiac arrest, life-threatening arrhythmias, respiratory depression.

Required Emergency Actions

Official regulatory guidance mandates that individuals must seek immediate medical attention upon the suspicion of an overdose or if severe symptoms occur. Hospital monitoring, including continuous ECG surveillance and immediate evaluation of serum electrolyte levels, is required.

Management involves specific supportive measures. While no specific antidote is known for the combination, intravenous Ca^2+ administration is documented as a functional antagonist used to stabilize severe cardiac effects. Symptomatic and supportive treatment is required, with hemodialysis listed as a necessary procedure for severe or refractory cases. Increased risk of severe toxicity is officially noted in patients with compromised renal function.

Therapeutic Uses of Polase

Polase is applied across domains where additional symptomatic support is needed, and is generally used in contexts marked by increased discomfort or tension due to potential physiological loss.

The supplement is commonly used to help manage symptom clusters related to physical discomfort, such as pervasive tiredness, generalized physical weakness, and musculoskeletal symptoms like spasms and cramps. The supplement is considered relevant for managing symptoms that create noticeable physiological strain.

The supplement generally assists with managing symptoms that create noticeable functional strain, and is applied in clinical settings involving acute or unstable symptom patterns, which includes periods of increased physiological loss due to excessive sweating, intense heat, or rigorous physical activity.

“The supplement may assist with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods.”

Quick Fact: Relief for Functional Strain

Polase is relevant in conditions where symptoms may intensify temporarily, presenting with systemic or localized discomfort linked to mineral imbalance. The supplement provides support that helps ease the overall symptom burden and supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Polase is a dietary supplement containing Potassium and Magnesium, and is primarily indicated for addressing deficiencies of these minerals, which can occur due to excessive sweating, intense physical activity, high-fiber diets that reduce absorption, or other states of increased need.

Who Can Use Polase?

The supplement is generally intended for adults experiencing mild to moderate symptoms of mineral salt deficiency, such as tiredness, physical fatigue, and muscle weakness, often associated with warm weather or demanding lifestyles. The product can typically be used during pregnancy and breastfeeding, but only after consulting with a doctor or gynecologist.

Contraindications and Warnings

Polase is not recommended for all individuals. The most significant caution is for patients with renal insufficiency (kidney problems), as they may have difficulty properly processing and eliminating excess potassium and magnesium, potentially leading to harmful accumulation. In such cases, or in the event of an overdose or prolonged use, medical advice must be sought.

Group General Recommendation Warning/Consultation Note
Adults Generally suitable. Do not exceed the recommended daily dose.
Children Not recommended under 3 years of age. Keep out of reach.
Pregnant/Nursing Use is possible. Consult a doctor before use.
Renal Insufficiency Not recommended/Avoid. Consult a doctor due to risk of mineral accumulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Polase, a supplement containing Potassium and Magnesium salts, has documented interaction considerations primarily related to its mineral components. These interactions fall into two principal categories: additive electrolyte effects and pharmacokinetic interference.

1. Interactions Affecting Electrolyte Balance

Combining Polase with other medicinal products that increase serum potassium levels carries a risk of additive pharmacodynamic effects, potentially leading to hyperkalemia. Interacting product categories include potassium-sparing diuretics (e.g., spironolactone) and certain agents that affect renal potassium excretion, such as ACE inhibitors and ARBs. Regulatory documents caution against concurrent use or require close monitoring.

2. Pharmacokinetic Interference

The Magnesium component can interfere with the oral absorption of specific co-administered medications by forming non-absorbable complexes (chelation). This reduces the systemic exposure of the affected drug. This is documented for agents such as tetracycline antibiotics, quinolone antibiotics, and bisphosphonates. To mitigate this interference, official guidance mandates separating the administration time of Polase from these medications by at least two to four hours.

3. Population-Specific Notes

The clinical significance of these interactions is heightened in individuals with impaired renal function, as reduced kidney clearance of both Potassium and Magnesium increases the systemic concentration, thereby increasing the risk of hyperkalemia and hypermagnesemia.

Mechanism of Action

Polase, containing potassium (typically as gluconate) and magnesium (typically as citrate), functions by modulating cellular ion concentrations across systemic compartments. Following oral administration and absorption, potassium ions K^+ are distributed to tissues, maintaining the principal intracellular cation concentration required for the resting membrane potential. This gradient is fundamentally dependent on the activity of the Na^+- K^+-ATPase pump, where K^+ serves as a critical substrate for the exchange mechanism.

Magnesium ions Mg^2+ act as a cofactor for over 300 enzymatic reactions, primarily involving the transfer of phosphate groups, which is essential for adenosine triphosphate (ATP) metabolism. Mg^2+ also directly influences transmembrane ion flux. Specifically, it acts as a physiological antagonist to calcium Ca^2+ at various sites, including muscle endplates, and is required for the proper function of the Na^+- K^+-ATPase pump itself. System-level physiological consequences involve the maintenance of normal muscle excitation-contraction coupling, neuronal signaling, and the modulation of vascular smooth muscle tone via ion channel regulation, collectively contributing to the stability of cellular bioenergetics and electrophysiological processes.

Dosage and Administration Information

How to Use Polase — Official Administration Guidelines

Polase is widely available as a mineral salt food supplement (Potassium and Magnesium) and is used according to manufacturer instructions, which define the standardized approach to its administration.

Administration Scope

Instruction Detail
Route of Administration Oral
Dosing Schedule (Typical) One sachet per dose. Maximum daily dose is generally restricted to 3 sachets (or 2 for concentrated variants like Polase Plus).
Timing in Relation to Meals Take the specified dose after the two main meals of the day.
Preparation Requirements The content of one sachet must be fully dissolved in a glass of water prior to ingestion.
Age-Group Rules The dosing schedule is for adults; the product label explicitly states to keep out of reach of children under 3 years old.
Course Duration Administration is recommended to continue for at least two weeks.

Instruction Classifications

Classification Detail
Administration Method Type Oral solution (following dissolution of granules)
Frequency Pattern Daily, typically administered in two to three divided doses.
Use-Context Constraints Requires mandatory pre-administration dissolution; subject to a defined maximum daily dose.

Resulting Procedural Structure

The required procedure for administration is a distinct two-step sequence:

  • Preparation: Dissolve the measured contents of one sachet in a full glass of water.
  • Timing: Ingest the resulting solution orally after one of the main meals, ensuring the maximum daily limit is not exceeded.

This structure standardizes the delivery of the mineral salts, prescribing the necessary steps for proper use, including the correct fluid requirement and maximum safe daily intake, as detailed in product information.

Recent Clinical Evidence

Research evidence / Overview of studies for Polase


Evidence for use in Reducing Tiredness and Fatigue

Polase, which provides magnesium and potassium, was studied for its application in research exploring feelings of tiredness and physical fatigue. The research examined these effects primarily in contexts where people might be more prone to losing these minerals, such as during periods of increased heat, heavy sweating, or following physical exertion. Studies of this kind often applied in studies examining patient-reported experiences, focusing on outcomes reflecting daily functioning or activity level.

The findings describe patterns observed in the studies where participants reported their perceived energy levels. For instance, in some research exploring short-term symptom changes, the data monitored patterns related to mineral supplementation and participant reports on the intensity of fatigue. However, the evidence was observed in some studies to be mixed, and a clear, consistent pattern across all research is not established. It is important to remember that these findings describe group patterns, not personal outcomes.

Evidence for use in Supporting Normal Muscle Function

The connection between magnesium and potassium and the function of muscles was evaluated in a number of research settings. This type of research is relevant in trials assessing short-term or episodic symptom patterns, particularly focusing on outcomes related to systemic or functional imbalance within the muscles. Studies monitored how the ingestion of these minerals relates to the function of muscles.

In various research scenarios, the findings indicate that maintaining adequate levels of magnesium and potassium is crucial for normal function. Some evidence was associated with the observation that when these minerals are adequately provided, studies monitored patterns related to proper muscle activity. This research helps contextualize how patients reported their experience related to muscle function during periods of conditions involving periods of heightened symptoms such as muscle discomfort or weakness.

What is still uncertain about Polase

Despite the existing research, there are clear gaps in the current evidence landscape. The research is ongoing to fully understand all the effects of Polase. A significant limitation is that the evidence quality varies across studies, and findings were mixed in certain areas.

Specifically, certainty remains low regarding the exact circumstances under which supplementation contributes to the most noticeable patient-reported outcomes describing perceived discomfort for people who are not clinically deficient in magnesium or potassium. Furthermore, research was studied for short-term changes, meaning that comparative evidence is lacking regarding its sustained effectiveness against other dietary or lifestyle adjustments over long periods. The evidence highlights what is known—and what is still uncertain—about the consistent pattern of changes reported across all research.

Key Studies & References

  1. The effect of magnesium supplementation on muscle function and strength: a systematic review

Frequently Asked Questions (FAQ)

Common questions about Polase (FAQ)

Q: Are there different versions of Polase available?

The product is available in multiple formulations and can come in different flavors. Official product information indicates that the product is supplied as granules for oral solution (sachets) or as tablets, and may include concentrated variants like Polase Plus. The specific name and form are listed on the packaging.


Q: Is Polase used to help with muscle cramps?

Regulatory documents state that the supplement is used for mineral deficiencies that can lead to symptoms like muscle weakness and discomfort. Since cramps are a common type of muscle discomfort related to potassium and magnesium imbalance, this is a relevant context for use. The intended action is to support normal muscle function.


Q: Is nausea a possible side effect listed for Polase?

Yes, gastrointestinal disturbances are among the adverse effects sometimes associated with mineral supplements. Official information states that side effects related to the digestive system may include nausea, stomach cramps, or diarrhea.


Q: Are there any signs that someone might be taking too much Polase?

Overdose or excessive intake is primarily associated with very high levels of potassium (hyperkalemia) or magnesium. Signs of this serious risk can include severe muscle weakness, extreme drowsiness, or a noticeably slow heartbeat. If an overdose is suspected, official warnings mandate immediate medical consultation.


Q: Does Polase interact with blood pressure medications?

Yes, regulatory warnings confirm that Polase can interact with certain types of blood pressure medications. Specifically, agents that increase potassium levels, such as ACE inhibitors, ARBs, or potassium-sparing diuretics, pose a risk. The product label advises consultation with a healthcare provider regarding use when taking these types of medications.


Q: Can Polase be taken long-term?

The product label typically recommends a minimum course of administration of at least two weeks. However, official warnings require medical consultation for use continuing for prolonged periods. This is due to the potential for mineral accumulation over time.


Q: Are there any specific lifestyle factors that might affect how Polase works?

Official usage rationales indicate that the product is intended for situations associated with increased mineral loss. These lifestyle factors include engaging in intense physical activity, periods of heavy sweating, or prolonged exposure to heat. The mineral salts are provided to help address the resulting imbalance.


Q: Does the efficacy of Polase change depending on the season?

The product’s intended use is directly tied to mineral loss that occurs due to heavy sweating and exposure to heat, conditions that are often seasonal. While the product itself doesn't change, the need for it is often greater during warmer months or high-activity periods when mineral loss is more significant.


Q: Can I mix Polase with juice or other drinks?

The official administration guidelines for the sachet form clearly state that the contents must be fully dissolved in a glass of water prior to ingestion. Deviating from the recommended liquid may potentially affect the stability, taste, or absorption of the mineral salts.


Q: Can Polase be crushed or split?

For the granule sachet form, the product is meant to be fully dissolved in water. If using the tablet form, the specific packaging instructions must be consulted. Official administration instructions define the proper use, as not all oral forms are designed to be altered.


Q: What are the general expectations for people who begin using Polase?

The intended effect, based on the product’s function and supporting evidence, is to help reduce feelings of tiredness and fatigue when these symptoms are related to mineral loss. The supplement aims to support the normal function of muscles and the nervous system by restoring mineral balance.


Q: Is Polase appropriate for use by elderly patients?

The product's use is generally directed toward the adult population. However, official warnings advise caution, particularly for older adults, due to the increased possibility of reduced kidney function. Since impaired kidney function is a major contraindication, the need for medical guidance is highlighted when considering use in this population.


Q: What does the official drug label say about using Polase if I have a heart condition?

Official safety warnings strongly caution against conditions that raise potassium levels, which pose a risk to heart function. The contraindication for high potassium (hyperkalemia) is crucial for cardiac health. The official warnings require consultation with a healthcare professional for individuals with pre-existing heart conditions.


Q: Is it possible for Polase to affect my blood tests?

Since the product is designed to increase the body's store of potassium and magnesium, it is possible for high intake to affect the measured levels of these specific minerals in blood tests. It is noted that individuals undergoing regular lab work may need to inform their healthcare provider about their use of the supplement.


Q: Where does Polase get its approval or regulatory status from?

Polase is regulated as a Food Supplement or Dietary Supplement, distinguishing it from a prescription drug. Its status is granted under the laws of the country where it is marketed and carries a specific registration from the relevant national health or food authority.


Q: Does Polase contain sugar or artificial sweeteners?

Yes, the product label provides a full list of ingredients as required by regulation. This list includes excipients like flavorings and non-active components such as any sugars or artificial sweeteners used to improve the taste.


Q: What are the inactive ingredients in Polase?

Official product information lists all inactive ingredients, which are sometimes called excipients. These components can include elements such as flavorings, specific types of acids, and stabilizers needed to ensure the stability and proper delivery of the active mineral salts.


Q: What happens if I miss a scheduled time to take Polase?

The general guidance provided in the Instructions for Use is usually to simply take the next scheduled dose at the customary time. Regulatory information advises against taking a double dose to compensate for the one that was missed.


Q: What does the regulatory information say about the use of Polase in people with diabetes?

While diabetes is not typically a direct contraindication, the product label must clearly indicate the presence of any sugar or artificial sweeteners. This ingredient information is essential for individuals who must manage their blood sugar levels carefully.


Q: How does the concentration of minerals in Polase compare to daily recommended intake?

As a food supplement, the product label is required to state the content of potassium and magnesium per dose. This information is typically expressed as a percentage of the established Daily Recommended Intake (DRI) or a similar reference value.


Q: Are there any official warnings about driving or operating machinery while using Polase?

Official product information contains a specific section addressing the product's effects on the ability to drive or operate machines. This information typically states that no known effects exist unless side effects like temporary dizziness occur.


Q: What is the official statement regarding Polase and potential allergic reactions?

Official safety information states that use must be discontinued if symptoms suggesting an allergic reaction (e.g., rash, swelling) occur. The product label details the active and inactive ingredients that may potentially trigger such reactions.


Q: Does Polase have any known interactions with alcohol?

Regulatory product information requires a specific section addressing known or theoretical interactions with food and alcohol. Therefore, the product label must be consulted for any specific warnings or guidance regarding co-ingestion with alcohol.

How should Polase be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory documentation outlines specific requirements for storing and disposing of Polase to maintain its integrity and safety. These requirements ensure the product remains stable until its expiration date.

Feature Requirement
Maximum Temperature Store at a temperature not exceeding 25 C.
Environmental Protection Store in a dry place to protect from moisture.
Packaging Must be kept in the original packaging.
Child Safety Keep the product out of reach of children.
Disposal Unused product and related waste must be disposed of in accordance with local regulations.

Regulatory instructions require that the product's storage conditions are strictly followed, including temperature constraints and protection from moisture. This helps preserve the product's stability. Disposal must follow local waste management regulations; the product should not be discarded casually.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Polase found in:

A-Z Index: